Share

April 19, 2022; 98 (16) Editorial

Racial- and Gender-Based Disparities in IV-Alteplase Declination

Looking for Barriers and Biases When Patients Say No

Tracy E. Madsen, Roy Hamilton
First published February 28, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200169
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
59

Share

Article Information

vol. 98 no. 16 647-648
DOI: 
https://doi.org/10.1212/WNL.0000000000200169
PubMed: 
35228333
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 28, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Tracy E. Madsen, MD, PhD and
    2. Roy Hamilton, MD, MS, FAAN
  1. Tracy E. Madsen, MD, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. <br>(1) Neurology, Editorial Board Member, 2021 - Present<br>

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. <br>NIH NHLBI K23HL140081 PI , 8/18-7/23<br> Signature: Tracy madsen Date: 1.5.22<br><br>

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Roy Hamilton, MD, MS, FAAN
    3. Scientific Advisory Boards:

    1. <br>1) I am the safety monitor for three NIH-funded research projects.<br>

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. <br>1) Starfish LLC; honorarium for speaking on diversity, inclusion, and equity in STEM<br>2) Alexion Pharmaceuticals, honorarium for speaking on diversity, inclusion, and equity in clinical trials and pharma<br>

    Editorial Boards:

    1. <br>(1)Cognitive and Behavioral Neurology, editorial board<br>member, 2015 to present<br>(2)Restorative Neurology and Neuroscience, editorial board<br>member, 2011 to present<br>(3) Senior editor, Neurobiology of Language, 2019 to present<br>(4) Associate Editor for Equity, Diversity, and Inclusion, Neurology <br>(and the Neurology family of journals), 2019 to present<br>

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. <br>I served as a consultant for Geurbet Ltd. on the development of <br>an FDA-mandated clinical trial. I received approximately $10000 <br>for this work over 2 years (2017-18) <br><br>I have served as a medical consultant for Neuronix LTD from, <br>2014 to 2018; I received approximately $10000 for this work.<br>

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. <br>1) NIH/NIA<br>5P30-AG-010124-27<br>Co-Investigator<br>7/15/97-6/30/19 <br><br>2) NIH/NIDCD<br>1 R01 DC012780-01A1 <br>Principal Investigator<br>7/01/2013 - 6/30/2019 <br><br>3) NIH/NIDCD<br>2-R01-DC-009209-11<br>Co-Investigator <br>6/01/2014 - 5/31/2019<br><br>4) NIH/NIDCR<br>DP5OD021352 <br>Co-Investigator <br>9/19/2015 - 08/31/2020<br> <br>5) NIH/NIDCD<br>1R01DC015359-01A1<br>Co-Investigator <br>4/01/2016 - 3/31/2021<br><br>6) University of Pennsylvania/Translational Neuroscience <br>Initiative <br>(TNI)<br>Co-Investigator<br>7/01/2016 - 6/30/2019<br> <br>7) NIH/NEI<br>R01EY022350 <br>Co-Investigator <br>9/01/2016 - 8/31/2021 <br><br>8) NIH/NINDS<br>5P30NS045839-12<br>Co-Investigator <br>2/1/2014-1/31/2018 <br><br>9) NIH/NINDS <br>1R01DC016800-01A1<br>Co-Investigator<br>10/1/17-9/30/22<br><br>10) Association for Frontotemporal Dementia <br>Principal Investigator<br>1/01/2016 – 12/31/2016<br><br>11) Dana Foundation<br>Principal Investigator <br>12/13/2012 - 4/24/2018<br><br>12)Department of Defense<br>PR191513<br>Principle investigator<br>7/01/20 – 6/30/23 <br><br>13)NIH/NIA<br>R01AG059763 <br>Principal Investigator<br> 7/01/19 - 6/30/2024<br> Signature: /Roy Hamilton/ Date: 1/15/22

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Emergency Medicine (T.E.M.), Warren Alpert Medical School of Brown University; Department of Epidemiology (T.E.M.), Brown University School of Public Health, Providence, RI; and Department of Neurology (R.H.) and Department of Physical Medicine and Rehabilitation (R.H.), University of Pennsylvania, Philadelphia.
  1. Correspondence
    Dr. Madsen tracy_madsen{at}brown.edu
View Full Text

Article usage

Article usage: February 2022 to July 2022

AbstractFullPdfSource
Feb 2022001Highwire
Mar 20220020Highwire
Apr 20224593625Highwire
May 20228537Highwire
Jun 20224112Highwire
Jul 20223474Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me